Literature DB >> 11453701

Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome.

U Chaisri1, M Nagata, H Kurazono, H Horie, P Tongtawe, H Hayashi, T Watanabe, P Tapchaisri, M Chongsa-nguan, W Chaicumpa.   

Abstract

Haemolytic uraemic syndrome (HUS) is characterized by haemolytic anaemia, thrombocytopenia and renal failure. Infection with enterohaemorrhagic Escherichia coli (EHEC), mainly O157:H7, has been strongly implicated as the major cause of HUS in children. The pathogenesis of HUS caused by the infection is not well understood and the defined sites of Stx in kidney of EHEC-infected humans has not been clearly demonstrated. The aim of this study was to investigate and compare the locations of Stx deposition in kidneys of paediatric and geriatric patients who died from enterohaemorrhagic E. coli O157 (EHEC) associated HUS, using an immunoperoxidase staining of the tissues. The study revealed that binding of Stx was relatively less and limited only to the renal tubules of an adult case (81 years old), while more binding was found at both renal tubules and glomeruli of an infant case (21 months old). The Stx binding in the infant's glomeruli was at podocytes, mesangial and endothelial cells. It has been known that young children are more susceptible than adults to HUS. One possibility for this is that the more extensive binding of the Stx to the kidney tissue of the paediatric patient might be due to the higher synthesis and expression of Stx receptors, i.e. Gb(3), in infants and less so in the aged individuals. However, other alternatives are possible, for example, the difference in stage of HUS in individual patients. Thus it is too early to draw any conclusion on this enigma and further investigation is required. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11453701     DOI: 10.1006/mpat.2001.0447

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  23 in total

Review 1.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

2.  Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.

Authors:  Erin K Lentz; Dinorah Leyva-Illades; Moo-Seung Lee; Rama P Cherla; Vernon L Tesh
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 3.  Shiga Toxin (Stx) Classification, Structure, and Function.

Authors:  Angela R Melton-Celsa
Journal:  Microbiol Spectr       Date:  2014-08

Review 4.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

5.  Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Tonia Zangari; Erica E Carroll; Alison D O'Brien
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

Review 6.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

7.  Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome.

Authors:  Deborah J Stearns-Kurosawa; Sun-Young Oh; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh; James Papin; Joel Henderson; Shinichiro Kurosawa
Journal:  Am J Pathol       Date:  2013-02-10       Impact factor: 4.307

8.  Shiga toxin 2 targets the murine renal collecting duct epithelium.

Authors:  Mitchell A Psotka; Fumiko Obata; Glynis L Kolling; Lisa K Gross; Moin A Saleem; Simon C Satchell; Peter W Mathieson; Tom G Obrig
Journal:  Infect Immun       Date:  2009-01-05       Impact factor: 3.441

9.  Hemolytic uremic syndrome (HUS)--incidence and etiologies at a regional Children's Hospital in 2001-2006.

Authors:  R J Pomajzl; M Varman; A Holst; A Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-08-16       Impact factor: 3.267

10.  Increased EHEC survival and virulence gene expression indicate an enhanced pathogenicity upon simulated pediatric gastrointestinal conditions.

Authors:  Charlène Roussel; Charlotte Cordonnier; Wessam Galia; Olivier Le Goff; Jonathan Thévenot; Sandrine Chalancon; Monique Alric; Delphine Thevenot-Sergentet; Francoise Leriche; Tom Van de Wiele; Valérie Livrelli; Stéphanie Blanquet-Diot
Journal:  Pediatr Res       Date:  2016-07-18       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.